X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with ASTRAZENECA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs ASTRAZENECA PHARMA - Comparison Results

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. ASTRAZENECA PHARMA FDC LTD./
ASTRAZENECA PHARMA
 
P/E (TTM) x 24.0 143.8 16.7% View Chart
P/BV x 4.8 21.8 21.9% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 FDC LTD.   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
ASTRAZENECA PHARMA
Mar-14
FDC LTD./
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1441,285 11.2%   
Low Rs79634 12.5%   
Sales per share (Unadj.) Rs47.6189.6 25.1%  
Earnings per share (Unadj.) Rs7.6-0.2 -3,737.3%  
Cash flow per share (Unadj.) Rs9.03.8 234.4%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.568.6 69.3%  
Shares outstanding (eoy) m177.8325.00 711.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.35.1 46.2%   
Avg P/E ratio x14.6-4,712.7 -0.3%  
P/CF ratio (eoy) x12.3249.6 4.9%  
Price / Book Value ratio x2.314.0 16.7%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,78423,988 82.5%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m1,2211,605 76.1%   
Avg. sales/employee Rs ThNM3,040.2-  
Avg. wages/employee Rs ThNM1,029.2-  
Avg. net profit/employee Rs ThNM-3.3-  
INCOME DATA
Net Sales Rs m8,4594,740 178.5%  
Other income Rs m39492 427.3%   
Total revenues Rs m8,8524,832 183.2%   
Gross profit Rs m2,070-130 -1,594.9%  
Depreciation Rs m249101 246.1%   
Interest Rs m310-   
Profit before tax Rs m2,184-139 -1,572.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0139 0.0%   
Tax Rs m6065 11,896.9%   
Profit after tax Rs m1,353-5 -26,584.5%  
Gross profit margin %24.5-2.7 -893.7%  
Effective tax rate %27.7-3.7 -756.8%   
Net profit margin %16.0-0.1 -14,896.6%  
BALANCE SHEET DATA
Current assets Rs m4,3552,726 159.7%   
Current liabilities Rs m1,7922,435 73.6%   
Net working cap to sales %30.36.1 492.9%  
Current ratio x2.41.1 217.1%  
Inventory Days Days4474 60.3%  
Debtors Days Days2541 60.5%  
Net fixed assets Rs m3,0251,035 292.2%   
Share capital Rs m17950 357.2%   
"Free" reserves Rs m8,243942 874.6%   
Net worth Rs m8,4531,716 492.6%   
Long term debt Rs m110-   
Total assets Rs m10,5574,156 254.0%  
Interest coverage x71.4NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.81.1 70.3%   
Return on assets %13.1-0.1 -10,705.4%  
Return on equity %16.0-0.3 -5,396.8%  
Return on capital %23.50-  
Exports to sales %13.35.7 233.5%   
Imports to sales %3.36.5 51.7%   
Exports (fob) Rs m1,126270 416.6%   
Imports (cif) Rs m283306 92.3%   
Fx inflow Rs m1,146375 306.0%   
Fx outflow Rs m355470 75.6%   
Net fx Rs m791-96 -827.6%   
CASH FLOW
From Operations Rs m1,485-8 -18,332.1%  
From Investments Rs m-620-146 425.2%  
From Financial Activity Rs m-753862 -87.3%  
Net Cashflow Rs m113709 15.9%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.7 0.3 1,566.7%  
FIIs % 7.5 15.7 47.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 9.1 208.8%  
Shareholders   23,730 12,856 184.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   STRIDES SHASUN LTD  AJANTA PHARMA  ALEMBIC LTD  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Energy Stocks Lose(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.4% while the Hang Seng is down 0.5%. The Shanghai Composite is trading up by 0.2%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jun 25, 2018 11:33 AM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS